National Association of Testing Authorities, Australia
Scope of Accreditation
St Vincent's Pathology
Site
St Vincent’s Hospital Pathology
Accreditation No.
2531
Site No.
2524
Date of Accreditation
20 Dec 1988
Contact
Ms Tram Lam P: +61 (03) 92314080
Availability
Services available to external clients
Supervision
GX (General)
Scope of Accreditation
Anatomical Pathology
ISO 15189 (2022)
- This facility complies with the relevant National Pathology Accreditation Advisory Council (NPAAC) requirements.
Human Pathology
Medicare expiry date
14 Feb 2025
Last Activity Date
05 Mar 2024
| Service | Product | Determinant |
|---|---|---|
| Anatomical pathology - Cytopathology - Non-gynaecological cytological investigations of body fluids, exudates, washings and brushings from non-squamous mucosal sites for the detection of malignancy | Cerebrospinal fluid (CSF); Ocular specimens; Other body fluids; Sputum; Urine; Vitreous specimens; Washings or brushings from other sites | Cytological examination; Review and reporting of cytology samples |
| Anatomical pathology - Cytopathology - Non-gynaecological cytological investigations of nipple discharge or smears from squamous mucosal sites for the detection of cancerous or precancerous changes | Nipple discharge | Cytological examination; Review and reporting of cytology samples |
| Anatomical pathology - Cytopathology - Non-gynaecological cytological investigations on samples obtained via fine needle aspiration biopsy | Fine needle aspirates (FNA) | Cytological examination; Rapid onsite evaluation (ROSE); Review and reporting of fine needle aspiration samples |
| Anatomical pathology - Tissue pathology - Examination of biopsy material | Formalin-fixed tissue; Fresh tissue | Review and reporting of biopsy material to identify or exclude morphological abnormalities |
| Anatomical pathology - Tissue pathology - Examination of biopsy material by electron microscopyReporting only | Gluteraldehyde tissue | Review and reporting of biopsy material to identify or exclude ultra-structural morphological abnormalities; Structured reporting |
| Anatomical pathology - Tissue pathology - Gene probes using paraffin fluorescence in situ hybridisation (FISH) | Formalin-fixed paraffin-embedded (FFPE) tissues | Detection of nucleic acid targets - Various |
| Anatomical pathology - Tissue pathology - Gene probes using paraffin in situ hybridisation techniques (chromogenic/silver) | Formalin-fixed paraffin-embedded (FFPE) tissues | Detection of nucleic acid targets - Various |
| Anatomical pathology - Tissue pathology - Immediate frozen section diagnosis | Fresh tissue | Intra-operative consultation and examination of biopsy material |
| Anatomical pathology - Tissue pathology - Immunohistochemical (immunofluorescence) investigation | Frozen tissue | Detection of antigenic targets - Various |
| Anatomical pathology - Tissue pathology - Immunohistochemical investigation | Formalin-fixed paraffin-embedded (FFPE) tissues | Detection of antigenic targets - Various |
| Molecular genetics - DNA extraction | Formalin-fixed paraffin-embedded (FFPE) tissues; Tissues | DNA storage for future analyses; Viable DNA |
| Molecular genetics - Genetic testing for chimerism and mosaic gene variants (cancer and somatic mosaicism) - Targeted genes | Formalin-fixed paraffin-embedded (FFPE) tissues; Tissues | MGMT promoter methylation analysis; MLH1 promoter methylation analysis |
| Molecular genetics - Genetic testing for chimerism and mosaic gene variants (cancer and somatic mosaicism) - Targeted panels for non-inherited (somatic) DNA/RNA changes | Extracted RNA; Formalin-fixed paraffin-embedded (FFPE) tissues; Tissues | Glioblastoma; Melanoma; Solid tumours |
| Molecular genetics - RNA extraction | Formalin-fixed paraffin-embedded (FFPE) tissues; Tissues | RNA storage for future analyses; Viable RNA |
| Molecular genetics/Cytogenetics - Bioinformatic analysis | Alignment files; DNA sequences; FASTQ files; RNA sequences; TXT files; VCF files | Primary analysis - Conversion of instrument file to FASTQ or FASTA file; Secondary analysis - Alignment and copy number analysis; Secondary analysis - Alignment and variant calling; Tertiary analysis - Data annotation and interpretation |
Biochemistry
ISO 15189 (2022)
Human Pathology
Medicare expiry date
14 Feb 2025
Last Activity Date
05 Mar 2024
| Service | Product | Determinant |
|---|---|---|
| Chemical pathology - Analysis of calculus | Renal calculi | Albumin; Calcium oxalate dihydrate (weddelite); Calcium phosphate; Cysteine; Hydrated calcium oxalate (whewellite); Magnesium ammonium phosphate - Struvite; Quartz (silica); Uric acid |
| Chemical pathology - Analysis of drugs for toxicological (non-legal) purposes and ingested or absorbed toxic chemicals | Plasma; Serum | Paracetamol (acetaminophen) |
| Plasma; Urine | Ethanol | |
| Urine | Amphetamines; Barbiturates; Benzodiazepines; Cannabis; Cocaine; Methadone; Opiates | |
| Chemical pathology - Biochemical genetic services for the diagnosis of metabolic and enzymological disorders | Cerebrospinal fluid (CSF) | β2-Transferrin |
| Chemical pathology - Biogenic amines | Urine | 5-Hydroxyindoleacetic acid (5-HIAA); Adrenaline; Catecholamines; Dopamine; Noradrenaline |
| Chemical pathology - Detection and/or quantitation of drugs for therapeutic monitoring | Blood | Tacrolimus |
| 6-Mercaptopurine; 6-Thioguanine | ||
| Plasma | Clozapine | |
| Plasma; Serum | Carbamazepine; Digoxin; Gentamicin (cidomycin, septopal, genticyn, garamycin); Lithium; Methotrexate; Paracetamol (acetaminophen); Phenytoin (dilantin); Salicylate; Valproate (valproic acid, epilim); Vancomycin | |
| Flecainide; Flucloxacillin; Flucytosine; Norclozapine; Warfarin | ||
| Chemical pathology - Detection and/or quantitation of tumour markers | Plasma; Serum | CA125 antigen (CA125); CA15-3 antigen (CA15-3); CA19-9 antigen (CA19-9) |
| Thyroglobulin | ||
| Carcinoembryonic antigen (CEA); Prostate specific antigen (PSA); α-Fetoprotein (AFP) | ||
| β2-Microglobulin (B2M) | ||
| Serum | Prostate specific antigen (PSA) - Free | |
| Chemical pathology - Determination of hormones and hormone binding proteins (other than thyroid function tests) | Plasma | Aldosterone; Renin |
| Plasma; Serum | Cortisol; Follicle stimulating hormone (FSH); Luteinising hormone (LH); Macroprolactin; Oestradiol; Parathyroid hormone (PTH); Progesterone; Prolactin | |
| C-peptide; Dehydroepiandrosterone sulfate (DHEAS); Insulin; Sex hormone binding globulin (SHBG); Testosterone | ||
| Dehydroepiandrosterone sulfate (DHEAS); Growth hormone; Insulin-like growth factor 1 (IGF-1, somatomedin C) | ||
| Urine | Cortisol | |
| Chemical pathology - Diagnosis and management of diabetes mellitus | Blood | Glycated haemoglobin (HbA1c) |
| Chemical pathology - Further investigation of cardiac function | Plasma; Serum | Troponin |
| Serum | N-Terminal-pro b-type natriuretic peptide (NT-proBNP) | |
| Chemical pathology - Further investigation of lipid profiles for diagnosis of types III and IV hyperlipidaemia | Plasma; Serum | HDL - Quantitation |
| Apolipoprotein A1; Apolipoprotein B; Lipoprotein a; Lipoprotein subclasses | ||
| Chemical pathology - Further investigation of renal and/or hepatic function | Blood | Alkaline phosphatase (ALP) isoenzymes |
| Plasma; Serum | Caeruloplasmin; Haptoglobins; α1-Antitrypsin | |
| Plasma; Serum; Urine | Uric acid | |
| Chemical pathology - Investigation and determination of hepatic, cardiac, bone, skeletal muscle and other profiles and metabolic studies | Cerebrospinal fluid (CSF) | Glucose; Lactate; Protein - Total |
| Plasma | Ammonia | |
| Plasma; Serum | Alanine aminotransferase; Albumin; Alkaline phosphatase; Amylase; Aspartate aminotransferase; Bilirubin - Any fractions; Bilirubin - Total; C-reactive protein (CRP); Calcium - Total; Carbon dioxide (CO2); Chloride; Cholesterol - Total; Creatinine; Glucose; Lactate; Lactate dehydrogenase (LDH); Lipase; Magnesium; Phosphate; Potassium; Protein - Total; Sodium; Triglycerides; Urea; γ-Glutamyltransferase | |
| Plasma; Serum; Urine | Osmolality | |
| Serum | Angiotensin converting enzyme (ACE) | |
| Urine | Amylase; Calcium - Total; Chloride; Creatinine; Glucose; Magnesium; Microalbumin; Phosphate; Potassium; Protein - Total; Sodium; Urea | |
| Chemical pathology - Investigation for folate deficiency | Serum | Folate |
| Chemical pathology - Investigation of Helicobacter pylori colonisation or eradication | Breath | C14 |
| Chemical pathology - Iron studies | Plasma; Serum | Ferritin; Iron; Transferrin |
| Chemical pathology - Quantitation of blood gases and other measurements (performed on the same specimen) | Blood | Calcium - Ionised; Carboxyhaemoglobin; Chloride; Glucose; Haemoglobin (Hb); Lactate; Methaemoglobin (MetHb); Partial pressure of carbon dioxide (pCO2); Partial pressure of oxygen (PO2); Potassium; Sodium; pH |
| Chemical pathology - Quantitation of vitamins | Blood | Pyridoxine (vitamin B6, pyridoxal, pyridoxamine); Thiamine (vitamin B1) |
| Plasma; Serum | 25-Hydroxyvitamin D; Cobalamin (vitamin B12) | |
| Chemical pathology - Tests for thyroid function | Plasma; Serum | Thyroid stimulating hormone (TSH); Thyroxine (T4) - Free; Triiodothyronine (T3) - Free |
| Chemical pathology - Trace element analysis | Plasma; Serum | Copper; Zinc |
| Immunopathology - Detection and/or quantitation and/or characterisation of autoantibodies | Plasma; Serum | Anti-thyroglobulin antibodies (Tg); Anti-thyroid peroxidase antibodies (TPO) |
| Anti-thyroid stimulation immunoglobulin antibodies (TSI) | ||
| Infertility and pregnancy tests including assisted reproductive technology - Diagnosis or follow up of threatened abortion and/or diagnosis of ectopic pregnancy | Plasma; Serum | Human chorionic gonadotropin (hCG) - Quantitative total |
| Molecular genetics - Assay for defined mutation or polymorphism (including pharmacogenetic testing) - Targeted genes | Blood | Apolipoprotein E genotyping |
| Molecular genetics - Investigation of constitutional genetic variants - Carrier testing - Targeted genes | Blood | Haemochromatosis |
| Molecular genetics - Investigation of constitutional genetic variants - Diagnostic testing - Targeted genes | Blood | Haemochromatosis |
Cytogenetics
ISO 15189 (2022)
Human Pathology
Medicare expiry date
14 Feb 2025
Last Activity Date
05 Mar 2024
| Service | Product | Determinant |
|---|---|---|
| Cytogenetics - Detection of defined, balanced and/or unbalanced chromosomal abnormalities by in situ hybridisation techniques | Blood; Bone marrow; Smears; Tissues; Tumour imprints | Cytogenetic analysis and reporting |
| Cytogenetics - Karyotype detection of balanced and/or unbalanced chromosome abnormalities | Blood; Bone marrow | Haematological abnormalities |
| Cytogenetics - Molecular karyotype (SNP microarray) detection of unbalanced chromosome abnormalities | Blood; Bone marrow; Tissues | Cytogenetic analysis and reporting |
Endocrine Research Laboratory
ISO 15189 (2012)
Human Pathology
Medicare expiry date
14 Feb 2025
Last Activity Date
05 Mar 2024
| Service | Product | Determinant |
|---|---|---|
| Chemical pathology - Determination of hormones and hormone binding proteins (other than thyroid function tests) | Plasma; Serum | Insulin |
Haematology
ISO 15189 (2022)
Human Pathology
Medicare expiry date
14 Feb 2025
Last Activity Date
05 Mar 2024
| Service | Product | Determinant |
|---|---|---|
| Haematology - Bone marrow examination | Bone marrow | Examination of aspirated material |
| Haematology - Diagnosis of thalassemia | Blood | Haemoglobin A2 (HbA2) - Quantitation; Haemoglobin F (HbF) - Quantitation |
| Haematology - Examination of blood films by special staining | Blood | Haemosiderin |
| Acid phosphatase; Alkaline phosphatase; Heinz bodies; Iron; Non-specific esterase | ||
| Malaria | ||
| Haematology - Foetal haemoglobin in maternal circulation | Blood | Detection and quantitation of foetal red cell antigens |
| Presence of foetal red blood cells | ||
| Haematology - Full blood examination | Blood | Differential number; Erythrocyte count (red blood cell count, RBCC); Haematocrit (packed cell volume, PCV); Haemoglobin (Hb); Leucocyte count (white blood cell count, WBCC); Platelet count; Red blood cell index or indices; Reticulocytes |
| Haemoglobin H (HbH) inclusions; Morphology | ||
| Haematology - Haemostasis related analysis (including special coagulation testing and platelet function tests) | Blood | Platelet aggregation |
| Platelet function (PFA) | ||
| Plasma | Activated partial thromboplastin time (APTT); Activated protein C (APC) resistance; Anti-Xa - Apixaban; Anti-Xa - Dabigatran; Anti-Xa - Rivaroxaban; Anti-Xa activity; Anti-thrombin III; D-dimer; Factor II; Factor IX; Factor V; Factor VII; Factor VIII; Factor X; Factor XI; Factor XII; Factor XIII; Fibrinogen; International normalised ratio (INR); Protein C and protein S; Reptilase time; Thrombin time (TT); Von Willebrand factor (vWF) | |
| Lupus anticoagulant | ||
| Haematology - Investigation of haemoglobinopathy (excluding thalassemia) | Blood | Haemoglobin S (HbS) - Presence |
| Haemoglobin instability | ||
| Haematology - Investigation of haemolysis | Blood | Paroxysmal nocturnal haemoglobinuria (PNH) screen |
| Cold agglutinins | ||
| Haematology - Limited blood examination | Blood | Erythrocyte (RBC) sedimentation rate (ESR) |
| Immunopathology - Characterisation of leucocyte surface antigens (including immunophenotyping) | Blood | CD123; CD19; CD3; CD34; CD4; CD45; CD56; CD79b; CD8; FMC7; T-cell receptor β (TCRb) |
| CD34 | ||
| Blood; Bone marrow | CD10; CD103; CD117; CD11b; CD11c; CD123; CD13; CD14; CD15; CD16; CD19; CD2; CD20; CD22; CD23; CD25; CD3; CD33; CD34; CD38; CD4; CD45; CD5; CD56; CD64; CD7; CD71; CD79b; CD8; FMC7; HLA-DR antigen; Kappa light chains; Lambda light chains; Myeloperoxidase; Terminal deoxynucleotidyl transferase (TdT) | |
| CD10; CD103; CD117; CD11b; CD11c; CD13; CD14; CD15; CD16; CD19; CD2; CD20; CD22; CD23; CD25; CD3; CD33; CD34; CD38; CD4; CD45; CD5; CD56; CD64; CD7; CD71; CD8; HLA-DR antigen; Kappa light chains; Lambda light chains; Myeloperoxidase; Terminal deoxynucleotidyl transferase (TdT) | ||
| Immunopathology - Procedures related to the collection, processing, storage and issue of human haemopoietic progenitor cellsProduct received from 16999-18528 | Haemopoietic progenitor cells | Processing; Storage (includes freezing/thawing) |
| Enumeration of CD34+ cells | ||
| Total leucocyte number | ||
| Immunopathology - Single HLA antigen typing | Blood | HLA-B27 |
| Molecular genetics - Assay for defined mutation or polymorphism (including pharmacogenetic testing) - Targeted genes | Blood | BCR-ABL gene rearrangement |
| Molecular genetics - Investigation of constitutional genetic variants - Carrier testing - Targeted genes | Blood | Factor V Leiden; Prothrombin variant |
| Molecular genetics - Investigation of constitutional genetic variants - Diagnostic testing - Targeted genes | Blood | Myelodysplastic syndromes |
Immunohaematology
ISO 15189 (2022)
Human Pathology
Medicare expiry date
14 Feb 2025
Last Activity Date
05 Mar 2024
| Service | Product | Determinant |
|---|---|---|
| Immunohaematology - Blood group antibody detection | Blood | Other blood group systems; Rh phenotypes |
| Immunohaematology - Blood grouping | Blood | ABO; RhD |
| Immunohaematology - Determination of compatibility of blood donor units | Blood | Direct antiglobulin test (DAT, direct Coombs test); Examination for blood group antibodies; Group checks of patient and donor; Identification of detected antibodies |
| Immunohaematology - Identification and quantitation of blood group antibodies | Blood | Other blood group antibodies; Red blood cell phenotyping; Rh |
| Antibody elution | ||
| Immunohaematology - Investigation of blood transfusion reactions | Blood products | Antibodies |
| Immunohaematology - Issue and release of blood and blood product for transfusion | Blood; Blood products; Cryoprecipitate; Fresh frozen plasma (FFP); Platelets | Issue and release of blood and blood products for transfusion |
| Immunohaematology - Storage and distribution of blood and blood components | Blood; Blood products; Cryoprecipitate; Fresh frozen plasma (FFP); Platelets | Compliance with transport, storage and distribution requirements of blood, products and components |
Immunology
ISO 15189 (2022)
Human Pathology
Medicare expiry date
14 Feb 2025
Last Activity Date
05 Mar 2024
| Service | Product | Determinant |
|---|---|---|
| Chemical pathology - Investigation and determination of hepatic, cardiac, bone, skeletal muscle and other profiles and metabolic studies | Plasma; Serum | C1 esterase inhibitor functional |
| Serum | C1 esterase inhibitor | |
| Immunopathology - Detection and/or quantitation and/or characterisation of autoantibodies | Cerebrospinal fluid (CSF); Serum | Anti-N-methyl-D-aspartate receptor antibodies (NMDA); Anti-contactin associated protein (CASPR); Anti-dipeptidyl aminopeptidase-like protein 6 antibodies (DPPX); Anti-gamma aminobutyric acid (GABA) B receptor antibodies; Anti-glutamate receptor antibodies (AMPA/NMDA); Anti-leucine rich glioma inactivated protein 1 antibodies (LGI 1) |
| Plasma; Serum | Rheumatoid factor | |
| Serum | Anti-myeloperoxidase antibodies (MPO); Anti-proteinase 3 antibodies (PR3) | |
| Anti-scleroderma antibodies | ||
| Anti-neuronal antibodies | ||
| Anti-ganglioside antibodies | ||
| Tryptase | ||
| Anti-RNA polymerase III antibodies (ARA, RNAP); Anti-adrenal cortex antibodies; Anti-ovarian antibodies (AOA) | ||
| Anti-liver-kidney microsomes antibodies (LKM) | ||
| Anti-insulin antibodies | ||
| Anti-extractable nuclear antigen antibodies (ENA) | ||
| Anti-intracellular substance antibodies; Anti-skin basement membrane antibodies | ||
| Anti-EJ antibodies; Anti-F actin antibodies; Anti-Jo-1 antibodies; Anti-Ku antibodies; Anti-Mi-2 antibodies; Anti-NXP2 antibodies; Anti-OJ antibodies; Anti-PL-12 antibodies; Anti-PL-7 antibodies; Anti-PML antibodies; Anti-Pm/Scl-100 antibodies; Anti-Pm/Scl-75 antibodies; Anti-Ro-52 antibodies; Anti-SUMO activating enzyme antibodies (SAE); Anti-Sp-100 antibodies; Anti-desmoglein-1 antibodies (DSG-1); Anti-desmoglein-3 antibodies (DSG-3); Anti-glycoprotein-210 antibodies (GP210); Anti-liver cytosol antibodies (LC-1); Anti-liver-kidney microsomes antibodies (LKM); Anti-melanoma differentiation associated gene 5 antibodies (MDA5); Anti-mitochondrial antibodies (AMA, AMA M1 and/or AMA M2); Anti-phospholipase A2 receptor antibodies (PLA2R); Anti-signal recognition particle antibodies (SRP); Anti-skin antibodies; Anti-soluble liver antigen antibodies (SLA); Anti-striated muscle antibodies; Anti-transcription intermediary factor antibodies (TIF1); Dermatology profile - BP180, BP230, desmoglein 1, desmoglein 3, envoplakin and collagen type VII | ||
| Anti-gastric parietal cell antibodies (GPC/PCA); Anti-mitochondrial antibodies (AMA, AMA M1 and/or AMA M2); Anti-smooth muscle antibodies (SMA) | ||
| Anti-nuclear antibodies (ANA) | ||
| Anti-neutrophil cytoplasmic antibodies (ANCA) | ||
| Anti-intrinsic factor antibodies (IF) | ||
| Anti-double stranded DNA antibodies (dsDNA) | ||
| Anti-Jo-1 antibodies; Anti-Pm/Scl antibodies; Anti-Ro antibodies; Anti-Ro-52 antibodies; Anti-Scl-70 antibodies; Anti-Smith antibodies (Sm); Anti-centromere protein B antibodies (Cenp-B); Anti-dense fine speckle 70 antibodies; Anti-extractable nuclear antigen antibodies (ENA); Anti-histone antibodies (AHA); Anti-nucleosome antibodies; Anti-proliferating cell nuclear antigen (PCNA); Anti-ribonucleoprotein antibodies (RNP); Anti-ribosomal P protein antibodies | ||
| Anti-cardiolipin antibodies (ACA); Anti-cyclic citrullinated peptide antibodies (CCP); Anti-gliadin antibodies (AGA); Anti-glomerular basement membrane antibodies (anti-GBM); Anti-tissue transglutaminase antibodies (tTG); Anti-β2-glycoprotein-I antibodies | ||
| Immunopathology - Detection of immunoglobulin E specific antibodies (to potential drug allergens) | Serum | Amoxicilloyl group; Ampicilloyl group; Cefaclor; Chlorhexidine; Morphine; Penicilloyl G; Penicilloyl V; Pholcodine; Suxamethonium (succinylcholine) |
| Immunopathology - Detection of immunoglobulin E specific antibodies (to potential epidermal and animal protein allergens) | Serum | Animal mix; Caged bird mix; Cat epithelium; Chicken feathers; Cow dander; Dog epithelium; Feather mix; Guinea pig epithelium; Horse dander; Horse epithelium; Mouse epithelium; Mouse urine proteins; Pigeon droppings; Rabbit epithelium; Rat urine proteins; Sheep epithelium |
| Immunopathology - Detection of immunoglobulin E specific antibodies (to potential food [egg and fowl] allergens) | Serum | Chicken; Egg white; Egg yolk |
| Immunopathology - Detection of immunoglobulin E specific antibodies (to potential food [fish, shellfish and molluscs] allergens) | Serum | Blue mussel; Codfish; Crab; Lobster; Octopus; Oyster; Red snapper; Salmon; Scallop; Seafood mix; Shrimp; Squid; Tuna; Whiting |
| Immunopathology - Detection of immunoglobulin E specific antibodies (to potential food [fruit and vegetable] allergens) | Serum | Apple; Apricot; Aubergine (eggplant); Avocado; Banana; Carrot; Celery; Cucumber; Garlic; Grape; Grapefruit; Green olive; Kiwi; Lemon citrus; Mango; Melon; Onion; Orange citrus; Papaya; Peach; Pear; Pineapple; Plum; Potato; Pumpkin; Strawberry; Tomato; Watermelon |
| Immunopathology - Detection of immunoglobulin E specific antibodies (to potential food [meat] allergens) | Serum | Beef; Meat mix; Mutton; Pork |
| Immunopathology - Detection of immunoglobulin E specific antibodies (to potential food [milk] allergens) | Serum | Casein; Cheese - Cheddar type; Goat milk; Milk |
| Immunopathology - Detection of immunoglobulin E specific antibodies (to potential food [miscellaneous] allergens) | Serum | Baker's yeast; Cacao; Coffee; Mushroom; Omega-5-gliadin; Staple food mix; Yeasts |
| Immunopathology - Detection of immunoglobulin E specific antibodies (to potential food [seeds, legumes and nuts] allergens) | Serum | Almond; Barley; Brazil nut; Cashew nut; Cereal mix; Chick pea; Coconut; Corn; Gluten; Green bean; Hazelnut; Lentil; Macadamia nut; Nut panel; Oat; Peanut; Pecan nut; Pinenut; Pistachio; Poppy seed; Red kidney bean; Rice; Rye; Sesame seed; Soy bean; Sweet chestnut; Walnut; Wheat |
| Immunopathology - Detection of immunoglobulin E specific antibodies (to potential food [spices] allergens) | Serum | Basil; Black pepper; Chilli pepper; Cinnamon; Coriander (cilantro); Ginger; Green pepper - Unripe seed |
| Immunopathology - Detection of immunoglobulin E specific antibodies (to potential grass pollen allergens) | Serum | Bahia grass; Bermuda grass; False oat-grass; Grass mix; Johnson grass; Kentucky blue; Rye grass; Timothy grass; Velvet grass |
| Immunopathology - Detection of immunoglobulin E specific antibodies (to potential insect allergens) | Serum | German cockroach; Mosquito |
| Immunopathology - Detection of immunoglobulin E specific antibodies (to potential microorganism allergens) | Serum | Alternaria tenius; Aspergillus fumigatus; Candida albicans; Cladosporium herbarum; Mucor racemosus; Penicillium chrysogenum (formerly Penicillium notatum); Pityrosporum orbiculare (Malassezia furfur); Rhizopus nigricans; Staphylococcus enterotoxins; Mould mix |
| Immunopathology - Detection of immunoglobulin E specific antibodies (to potential mite allergens) | Serum | Dermatophagoides farinae house dust mite; Dermatophagoides pteronyssinus house dust mite; House dust - Hollister-Stier; House dust mite mix |
| Immunopathology - Detection of immunoglobulin E specific antibodies (to potential occupational allergens) | Serum | Formaldehyde/formalin; Latex; Sunflower seed; α-Amylase |
| Immunopathology - Detection of immunoglobulin E specific antibodies (to potential tree pollen allergens) | Serum | Acacia; Australian pine; Eucalyptus; Italian/Mediterranean/funeral cypress; Olive; Silver birch; Sycamore; Tree mix |
| Immunopathology - Detection of immunoglobulin E specific antibodies (to potential venom allergens) | Serum | Common wasp (yellow jacket) venom; Honey bee venom; Paper wasp venom |
| Immunopathology - Detection of immunoglobulin E specific antibodies (to potential weed pollen allergens) | Serum | Common ragweed; Plantain - English; Weed mix |
| Immunopathology - Quantitation of complement proteins | Plasma; Serum | Complement components C3 and C4 |
| Other complement components or breakdown product; Total haemolytic complement | ||
| Immunopathology - Quantitative and/or qualitative investigation of proteins | Cerebrospinal fluid (CSF) | Oligoclonal bands |
| Plasma; Serum | Detection and quantitation of free kappa and free lambda light chains | |
| Cryofibrinogen; Cryoglobulins | ||
| Serum | Protein classes | |
| Urine | Protein classes | |
| Immunopathology - Quantitative investigations of immunoglobulins and immunoglobulins subclasses | Plasma; Serum | Total immunoglobulin E |
| Total immunoglobulin A; Total immunoglobulin G; Total immunoglobulin M | ||
| Serum | Immunoglobulin subclasses; Total immunoglobulin G |
Microbiology
ISO 15189 (2022)
Human Pathology
Medicare expiry date
14 Feb 2025
Last Activity Date
05 Mar 2024
| Service | Product | Determinant |
|---|---|---|
| Immunopathology - Quantitative and/or qualitative investigation of proteins | Faeces | Calprotectin |
| Infertility and pregnancy tests including assisted reproductive technology - Diagnosis of pregnancy | Urine | Human chorionic gonadotropin (hCG) |
| Microbiology - Bacteriology - Detection of pathogenic bacteria | Aspirates; Blood; Cerebrospinal fluid (CSF); Ear swabs; Eye swabs; Faeces; Fluids; General swabs; Genital swabs; Nasal swabs; Respiratory specimens; Skin; Sputum; Synovial fluid; Throat swabs; Tissues | Streptococcus group B screening; Bacteria; Pathogenic microorganisms |
| Aspirates; Blood; Cerebrospinal fluid (CSF); Ear swabs; Eye swabs; Faeces; Fluids; General swabs; Genital swabs; Nasal swabs; Respiratory specimens; Skin; Sputum; Synovial fluid; Throat swabs; Tissues; Urine | Antibiotic susceptibility; Bacteria; Pathogenic microorganisms | |
| Bacteria; Pathogenic identification; Pathogenic microorganisms | ||
| Bacteria; Pathogenic identification; Pathogenic microorganisms | ||
| Biopsy specimens; Tissues | Helicobacter pylori | |
| Blood | Bacteria; Pathogenic microorganisms | |
| Blood; Cerebrospinal fluid (CSF); Fluids; General swabs; Respiratory specimens; Synovial fluid; Tissues; Urine | Bacteria; Casts; Crystals; Epithelial cells; Erythrocytes (red blood cells, RBC); Leucocytes (white blood cells, WBC) | |
| Bacteria | ||
| Urine | Bilirubin; Epithelial cells; Erythrocytes (red blood cells, RBC); Glucose; Ketones; Leucocytes (white blood cells, WBC); Nitrite; Proteins; Specific gravity; Urobilinogen; pH | |
| Microbiology - Environmental investigations and/or infection control (Clinical non-human testing) | Air | Bacterial growth - Sterility |
| Blood transfusion bags; Gastrointestinal endoscopes; Vascular catheter tips | Bacterial growth - Sterility | |
| Dialysis waters | Bacterial growth - Sterility | |
| Environmental swabs | Bacterial organism identification - Carbapenem resistant Enterobacteriaceae (CRE); Bacterial organism identification - Methicillin-resistant Staphylococcus aureus (MRSA); Bacterial organism identification - Vancomycin-resistant Enterococcus (VRE) | |
| Spore strips | Bacterial growth - Sterility | |
| Microbiology - Molecular biology - Detection, characterisation and/or quantitation of microbial nucleic acids (bacteria) | Bacterial isolates; Blood culture; Dry swabs; Faeces | Carbapenem resistant Enterobacteriaceae (CRE); Vancomycin resistant Enterococci (VRE) |
| Dry swabs | Treponema pallidum | |
| Dry swabs; Urine | Mycoplasma genitalium; Mycoplasma hominis; Ureaplasma parvum; Ureaplasma urealyticum | |
| Chlamydia trachomatis; Neisseria gonorrhoeae | ||
| Faeces | Clostridioides difficile; Clostridioides difficile toxin | |
| Respiratory specimens | Bordetella parapertussis; Bordetella pertussis; Chlamydophila pneumoniae; Chlamydophila psittaci; Legionella pneumophila; Mycoplasma pneumoniae | |
| Urine | Legionella pneumophila; Streptococcus pneumoniae | |
| Microbiology - Molecular biology - Detection, characterisation and/or quantitation of microbial nucleic acids (fungi) | Hair; Nails; Skin scrapings | Dermatophyte identification |
| Microbiology - Molecular biology - Detection, characterisation and/or quantitation of microbial nucleic acids (mycobacteria) | Bacterial isolates; Bronchial washings; Bronchoalveolar lavage; Respiratory specimens; Sputum | Mycobacterium tuberculosis; Mycobacterium rifampicin resistance rpoB |
| Microbiology - Molecular biology - Detection, characterisation and/or quantitation of microbial nucleic acids (protozoan parasites) | Faeces; Liver aspirate | Cryptosporidium spp.; Entamoeba histolytica; Giardia lamblia |
| Microbiology - Molecular biology - Detection, characterisation and/or quantitation of microbial nucleic acids (viruses) | Cerebrospinal fluid (CSF) | Parechovirus |
| Cerebrospinal fluid (CSF); Eye swabs; Faeces; Genital swabs; Tissues; Urine | Adenovirus; Cytomegalovirus (CMV); Enterovirus; Herpes simplex virus (HSV); Varicella zoster virus (VZV) | |
| Faeces | Norovirus | |
| Nasopharyngeal swabs; Throat swabs | Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2, COVID) | |
| Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2, COVID) | ||
| Plasma; Serum; Urine | BK virus; Cytomegalovirus (CMV) | |
| Respiratory specimens | Adenovirus; Human metapneumovirus; Influenza A virus; Influenza B virus; Parainfluenza virus type 1/2/3/4; Respiratory syncytial virus (RSV) A/B; Rhinovirus | |
| Influenza A virus; Influenza B virus; Parainfluenza virus type 1/2/3/4; Respiratory syncytial virus (RSV) A/B | ||
| Microbiology - Molecular biology - Microbial genotyping | Plasma; Serum | Hepatitis C virus (HCV) subtypes |
| Microbiology - Molecular biology - Quantitation of microbial nucleic acids | Plasma; Serum | Human immunodeficiency virus (HIV) RNA viral load |
| Hepatitis B virus (HBV) viral load; Hepatitis C virus (HCV) viral load | ||
| Microbiology - Mycobacteriology - Detection and identification of mycobacteria | Other body fluids; Respiratory specimens; Sputum; Tissues; Urine | Mycobacteria identification |
| Mycobacteria identification | ||
| Mycobacteria identification | ||
| Microbiology - Mycobacteriology - Tests for antigen lymphocyte stimulation | Blood | Mycobacterial antigen lymphocyte stimulation |
| Microbiology - Mycology - Detection, isolation and/or identification of yeasts and/or fungal elements | Cerebrospinal fluid (CSF); Fluids; Hair; Nails; Ocular specimens; Respiratory swabs; Skin scrapings; Tissues | Fungi susceptibility |
| Fungi identification; Yeasts identification | ||
| Fungi identification; Yeasts identification | ||
| Cerebrospinal fluid (CSF); Serum | Cryptococcus antigen | |
| Fluids; Nails; Skin scrapings; Tissues | Fungi identification | |
| Microbiology - Parasitology - Detection of ova, cysts and parasites | Blood | Malaria |
| Corneal scrapings | Acanthamoeba spp. | |
| Faeces | Cysts; Ova; Parasites | |
| Strongyloides stercoralis | ||
| Microbiology - Serology of infection - Microbial antibody and/or antigen detection and/or quantitation | Faeces | Clostridioides difficile toxin; Clostridium difficile glutamate dehydrogenase; Helicobacter pylori |
| Plasma; Serum | Infectious mononucleosis | |
| Serum | Cytomegalovirus (CMV) IgG avidity; Epstein-Barr virus nuclear antigen; Epstein-Barr virus viral capsid antigen; Helicobacter pylori IgG antibody; Hepatitis A virus antibody (anti-HAV) - IgM; Hepatitis B virus envelope antibody (anti-HBe); Hepatitis B virus envelope antigen (HBe Ag); Hepatitis C virus (HCV); Herpes simplex virus (HSV); Human T-lymphotropic virus type I/II (HTLV-I/II); Measles virus; Mumps virus; Mycoplasma spp.; Parvovirus; Toxoplasma; Varicella zoster virus (VZV) | |
| Cytomegalovirus (CMV); Hepatitis A virus (HAV); Hepatitis B virus core antibody (anti-HBc) - Total; Hepatitis B virus surface antibody (anti-HBs); Hepatitis B virus surface antigen (HBs Ag); Hepatitis B virus surface antigen (HBs Ag) - Confirmatory; Hepatitis C virus (HCV); Human immunodeficiency virus (HIV); Rubella IgG antibody; Syphilis Treponema pallidum antibody | ||
| Echinococcus spp. | ||
| Microbiology - Virology - Detection of pathogenic viruses | Faeces | Adenovirus; Rotavirus |
St Vincent’s Private Hospital Intensive Care Unit
ISO 15189 (2022)
Human Pathology
Medicare expiry date
14 Feb 2025
Last Activity Date
05 Mar 2024
| Service | Product | Determinant |
|---|---|---|
| Chemical pathology - Quantitation of blood gases and other measurements (performed on the same specimen) | Blood | Calcium - Ionised; Chloride; Glucose; Haemoglobin (Hb); Lactate; Partial pressure of carbon dioxide (pCO2); Partial pressure of oxygen (PO2); Potassium; Sodium; pH |
St Vincent’s Private Hospital Special Care Nursery
ISO 15189 (2022)
Human Pathology
Medicare expiry date
14 Feb 2025
Last Activity Date
05 Mar 2024
| Service | Product | Determinant |
|---|---|---|
| Chemical pathology - Investigation and determination of hepatic, cardiac, bone, skeletal muscle and other profiles and metabolic studies | Blood | Glucose |
| Chemical pathology - Quantitation of blood gases and other measurements (performed on the same specimen) | Blood | Base excess; Bicarbonate; Lactate; Oxygen saturation (sO2); Partial pressure of carbon dioxide (pCO2); Partial pressure of oxygen (PO2); Total carbon dioxide (TCO2); pH |
St Vincent’s Public Hospital Emergency Department
ISO 15189 (2012)
Human Pathology
Medicare expiry date
14 Feb 2025
Last Activity Date
05 Mar 2024
| Service | Product | Determinant |
|---|---|---|
| Chemical pathology - Quantitation of blood gases and other measurements (performed on the same specimen) | Blood | Calcium - Ionised; Chloride; Glucose; Haemoglobin (Hb); Lactate; Partial pressure of carbon dioxide (pCO2); Partial pressure of oxygen (PO2); Potassium; Sodium; pH |
St Vincent’s Public Hospital Intensive Care Unit
ISO 15189 (2022)
Human Pathology
Medicare expiry date
14 Feb 2025
Last Activity Date
05 Mar 2024
| Service | Product | Determinant |
|---|---|---|
| Chemical pathology - Quantitation of blood gases and other measurements (performed on the same specimen) | Blood | Calcium - Ionised; Chloride; Glucose; Haemoglobin (Hb); Lactate; Partial pressure of carbon dioxide (pCO2); Partial pressure of oxygen (PO2); Potassium; Sodium; pH |
St Vincent’s Public Hospital Medical Imaging – Ground Floor
ISO 15189 (2022)
Human Pathology
| Service | Product | Determinant |
|---|---|---|
| Chemical pathology - Investigation and determination of hepatic, cardiac, bone, skeletal muscle and other profiles and metabolic studies | Blood | Creatinine |
St Vincent’s Public Hospital Private Medical Imaging – Healy Basement
ISO 15189 (2022)
Human Pathology
| Service | Product | Determinant |
|---|---|---|
| Chemical pathology - Investigation and determination of hepatic, cardiac, bone, skeletal muscle and other profiles and metabolic studies | Blood | Creatinine |
The only data displayed is that deemed relevant and necessary for the clear description of the activities and services covered by the scope of accreditation.
Grey text appearing in a SoA is additional freetext providing further refinement or information on the data in the preceding line entry.
Accreditation No.
2531
Site No.
2524
Print date
26 Nov 2024
END OF SCOPE